• [1] 
    Moos RH, Moos BS. Long-term influence of duration and intensity of treatment on previously untreated individuals with alcohol use disorders. Addiction 2003;98:325228.
  • [2] 
    Etheridge RM, Craddock SG, Hubbard RL, Rounds-Bryant JL. The relationship of counselling and self-help participation to patient outcomes in DATOS. Drug Alcohol Depend 1999;57:99112.
  • [3] 
    Rabinowitz J, Marjefsky S. Predictors of being expelled from and dropping out of alcohol treatment. Psychiat Serv 1998;49:1879.
  • [4] 
    Stark MJ. Dropping out of substance abuse treatment: a clinically oriented review. Clin Psychol Rev 1992;12:93116.
  • [5] 
    Meier P. A national survey of retention in residential rehabilitation services. National Treatment Agency for Treatment Substance Misuse. London: National Treatment Agency, 2005.
  • [6] 
    Moos R, King M. Participation in community residential treatment and substance abuse patients' outcomes at discharge. J Subst Abuse Treat 1997;14:7180.
  • [7] 
    Harris R, Linn M, Pratt T. A comparison of dropouts and disciplinary discharges from a therapeutic community. Int J Addict 1990;15:74956.
  • [8] 
    Anderson S, Berg J. The use of a sense of coherence test to predict drop-out and mortality after residential treatment of substance abuse. Addict Res Theory 2001;9:23951.
  • [9] 
    Ball S, Carroll KM, Canning-Ball M, Rounsaville BJ. Reasons for dropout drug abuse treatment: symptoms, personality, and motivation. Addict Behav 2006;31:32030.
  • [10] 
    Claus R, Kindleberger L. Engaging substance abusers after centralized assessment: predictors of treatment entry and dropout. J Psychoactive Drugs 2002;34:2531.
  • [11] 
    Maglione M, Chao B, Aglin M. Correlates of outpatient drug treatment drop-out among methamphetamine users. J Psychoactive Drugs 2000;32:2218.
  • [12] 
    Evans E, Li L, Hser Y. Client and program factors associated with dropout from court mandated drug treatment. Eval Program Plann 2009;32:20412.
  • [13] 
    Joe G, Simpson D, Broome K. Retention and patient engagement models for different treatment modalities in DATOS. Drug Alcohol Depend 1999;57:11325.
  • [14] 
    Ryan R, Plant R, O'Malley S. Initial motivations for alcohol treatment: relations with patient characteristics, treatment involvement, and dropout. Addict Behav 1995;20:27997.
  • [15] 
    Daly JE, Pelowski S. Predictors of dropout among men who batter: a review of studies and implications for research and practice. Violence Vict 2000;15:13760.
  • [16] 
    Grosenick JK, Hatmaker CM. Perceptions of the importance of physical setting in substance abuse treatment. J Subst Abuse Treat 2000;18:2939.
  • [17] 
    Caplehorn J, Hartel D, Irwig L. Measuring and comparing the attitudes and beliefs of staff working in New York methadone maintenance clinics. Subst Use Misuse 1997;32:399413.
  • [18] 
    Humphreys K, Noke J, Moos RH. Recovering substance abuse staff members' beliefs about addiction. J Subst Abuse Treat 1996;13:758.
  • [19] 
    Reid G, Crofts N, Hocking J. Needs analysis for primary health care among the street drug using community in Footscray. Melbourne: The Centre for Harm Reduction, Macfarlane Burnet Centre for medical Research, 2000.
  • [20] 
    Gaume J, Gmel G, Faouzi M, Daeppen J. Counselor skill influences outcome of brief motivational interventions. J Subst Abuse Treat 2009;37:1519.
  • [21] 
    Meier PS, Donmall MC, McElduff P, Barrowclough C, Heller RF. The role of early therapeutic alliance in predicting drug treatment dropout. Drug Alcohol Depend 2006;83:5764.
  • [22] 
    Melnick G, Wexler HK, Chaple M, Banks S. The contribution of consensus within staff and client groups as well as concordance between staff and clients to treatment engagement. J Subst Abuse Treat 2006;31:27785.
  • [23] 
    Melnick G, Wexler HK, Cleland CM. Client consensus on beliefs about abstinence: effects on substance abuse treatment outcomes. Drug Alcohol Depend 2008;93:307.
  • [24] 
    Petry RK, Bickel WK. Therapeutic alliance and psychiatric severity as predictors of completion of treatment for opioid dependence. Psychiatr Serv 1999;50:21927.
  • [25] 
    Harris AHS, McKellar JD, Moos RH, Schaefer JA, Cronkite RC. Predictors of engagement in continuing care following residential substance use disorder treatment. Drug Alcohol Depend 2006;84:93101.
  • [26] 
    Brener L, Von Hippel W, Kippax S, Preacher K. The role of physician and nurse attitudes in the health care of injecting drug users. Subst Use Misuse (in press).
  • [27] 
    McLaughlin D, McKenna H, Leslie J. The perceptions and aspirations illicit drug holders hold toward health care staff and the care they receive. J Psychiatr Ment Health Nurs 2000;7:43541.
  • [28] 
    Brener L, Von Hippel W, Kippax S. Health care workers and discrimination towards injecting drug users with hepatitis C: does greater contact lead to less prejudice. Int J Drug Policy 2007;18:3817.
  • [29] 
    Von Hippel W, Brener L, Von Hippel C. Implicit prejudice toward injecting drug users predicts job turnover intentions among drug and alcohol nurses. Psychol Sci 2008;19:711.
    Direct Link:
  • [30] 
    Greenwald AG, Poehlman TA, Uhlmann E, Banaji MR. Understanding and using the Implicit Association Test: III. Meta-analysis of predictive validity. J Perso Soc Psychol 2009;97:1741.
  • [31] 
    Link BG, Phelan JC. Stigma and its public health implications. Lancet 2006;367:5289.
  • [32] 
    Paterson BL, Backmund M, Hirsch G, Yim C. The depiction of stigmatization in research about hepatitis C. Int J Drug Policy 2007;18:36473.
  • [33] 
    Bogart LM, Bird ST, Walt LC, Delahanty DL, Figler JL. Association of stereotypes about physicians to health care satisfaction, help-seeking behaviour, and adherence to treatment. Soc Sci Med 2004;58:104958.
  • [34] 
    Facione N, Miaskowski C, Dodd M, Paul S. The self-reported likelihood of patient delay in breast cancer: new thoughts for early detection. Prevent Med 2000;34:397407.
  • [35] 
    Denzin N. The research act: a theoretical introduction to sociological methods. Chicago: Aldine, 1970.
  • [36] 
    Kimchi J, Polivka B, Stevenson J. Triangulation in action. Admin Sci Quart 1991;24:60211.
  • [37] 
    Morse J. Principles of mixed methods and multimethod research design. In: TashakkoriA, TeddlieC, eds. Handbook of mixed methods in social and behavioral research. London: Sage, 2003:189208.
  • [38] 
    Elliott A, Chapman S. ‘Heroin hell of their own making’: construction of heroin users in the Australian press 1992–97. Drug Alcohol Rev 2000;19:191201.
  • [39] 
    Gossop M, Darke S, Griffiths P, et al. The Severity of Dependence Scale (SDS): psychometric properties of the SDS in English and Australian samples of heroin, cocaine and amphetamine users. Addiction 1995;90:60714.
  • [40] 
    Joe G, Simpson D, Broome K. Effects of readiness for drug abuse treatment on client retention and assessment of process. Addiction 1998;93:117790.
  • [41] 
    Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol 2006;3:77101.
  • [42] 
    Buchanan J, Young L. The war on drugs—a war on drug users? Drugs Educ Prev Policy 2000;7:40922.
  • [43] 
    Lawless S, Kippax S, Crawford J. Dirty, diseased and undeserving: the positioning of HIV positive women. Soc Sci Med 1996;43:13717.
  • [44] 
    Strenta AC, Kleck RE. Physical disability and the perception of social interaction: it's not what you look at but how you look at it. Perso Soc Psychol Bull 1984;10:27988.
  • [45] 
    Link BG, Struening EL, Neese-Todd S, Asmussen S, Phelan JC. The consequences of stigma for the self-esteem of people with mental illnesses. Psychiatr Serv 2001;52:16216.
  • [46] 
    Strenta AC, Kleck RA. Physical disability and the attribution dilemma: perceiving the causes of social behavior. J Soc Clin Psychol 1985;3:12942.
  • [47] 
    Day C, Ross J, Dolan K. Hepatitis C-related discrimination among heroin users in Sydney: drug user or hepatitis C discrimination? Drug Alcohol Rev 2003;22:31721.
  • [48] 
    Hopwood M, Treloar C, Bryant J. Hepatitis C and injecting-related discrimination in New South Wales, Australia. Drugs Educ Prevent Policy 2006;13:6175.
  • [49] 
    Treloar C, Hopwood M. Infection control in the context of hepatitis C disclosure: implications for education of healthcare professionals. Educ Health 2004;17:18391.
  • [50] 
    Wolfe D. Paradoxes in antiretrovial treatment for injecting drug users: access, adherence and structural barriers in Asia and the former Soviet Union. Int J Drug Policy 2007;18:24654.